Clinical Trials Logo

Diffuse Diabetic Macular Edema clinical trials

View clinical trials related to Diffuse Diabetic Macular Edema.

Filter by:
  • None
  • Page 1

NCT ID: NCT01218750 Recruiting - Clinical trials for Diffuse Diabetic Macular Edema

Triple Therapy for Diffuse Diabetic Macular Edema

TTDDME
Start date: December 2008
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the safety end efficacy of combined phakoemulsification and vitrectomy with retinal endophotocoagulation and intraoperative use of bevacizumab in patients with diffuse diabetic macular edema (DDME), to determine the possible preoperative and intraoperative factors that might influence surgical outcomes.

NCT ID: NCT00999791 Recruiting - Clinical trials for Diffuse Diabetic Macular Edema

Intravitreal Diclofenac Versus Avastin as Primary Treatment of Diffuse Diabetic Macular Edema

Start date: July 2009
Phase: Phase 1
Study type: Interventional

Diffuse Macular Edema is the main cause of visual disorders in diabetic patients. Diclofenac is a cheap drug available in most of treatment centers.in animal studies the safe dosage is identified that can be used in diffuse diabetic macular edema for treatment. in this study, we are going to compare the effect of intra vitreal injection of Diclofenac and Bevacizumab in primary treatment of diffuse diabetic macular edema.

NCT ID: NCT00886808 Completed - Clinical trials for Diffuse Diabetic Macular Edema

Safety Study of iCo-007 Intravitreal Injection to Treat Diabetic Macular Edema

Start date: February 2008
Phase: Phase 1
Study type: Interventional

The goal of the study is to evaluate the safety and tolerability of 4 different doses of iCo-007 Intravitreal Injection in patients with diffuse diabetic macular edema.

NCT ID: NCT00600301 Withdrawn - Clinical trials for Diffuse Diabetic Macular Edema

Vitrectomy Without Internal Limiting Membrane Removal in the Treatment of Diffuse Diabetic Macular Edema: a Comparative Kenalog Vs Bevacizumab Intravitreal Injection Vs Control Study

Start date: January 2008
Phase: Phase 3
Study type: Interventional

Diabetic macular edema is the most common cause of visual loss among patients with diabetic retinopathy. Pars plana vitrectomy has been reported to be effective for the treatment of diabetic macular edema. Previous report showed a limited improvement in visual acuity and macular thickness posterior intraoperative triamcinolone acetonide. Bevacizumab intravitreal injection has been proven be effective in the treatment of diabetic macular edema, in recent publications. The purpose of this study is to evaluate whether vitrectomy with and without intravitreal triamcinolone acetonide and bevacizumab injection affects vision outcome and macular thickness in patients with diabetic macular edema.

NCT ID: NCT00571142 Terminated - Clinical trials for Diffuse Diabetic Macular Edema

Vitrectomy and Bevacizumab for Diffuse Diabetic Macular Edema

Start date: November 2007
Phase: Phase 3
Study type: Interventional

To Evaluate combined effect of vitrectomy and bevacizumab to stabilize retinal thickness and visual acuity in patients with diffuse diabetic macular edema and their relation to renal disease.

NCT ID: NCT00567372 Withdrawn - Clinical trials for Diffuse Diabetic Macular Edema

POSTERIOR SUB-TENON'S Avastin

Start date: June 2008
Phase: Phase 4
Study type: Interventional

Posterior sub-tenon's injection of bevacizumab decreased diffuse diabetic macular edema